Wong B Y W, Hickman S, Richards M, Jassar P, Wilson T
Department of ENT, Pinderfields General Hospital, Wakefield, UK.
Department of Paediatric Haematology, Leeds Children Hospital, Leeds, UK.
Clin Otolaryngol. 2015 Dec;40(6):704-14. doi: 10.1111/coa.12504.
Otogenic paediatric cerebral venous sinus thrombosis (CVST) is rare but has potential clinical sequelae. Its management has long been debated mainly concerning the role of surgery and the use of anticoagulant therapy.
To review the current literature and examine the medical and surgical management of paediatric otogenic CVST and its clinical and radiological outcome.
Systematic review.
The electronic databases (MEDLINE, EMBASE, Cochrane) were searched from inception to November 2014 using text words 'cerebral venous sinus thrombosis OR cerebral venous thrombosis OR lateral sinus thrombosis OR sigmoid sinus thrombosis' AND 'otogenic OR mastoiditis OR otitis media' AND 'children OR paediatric OR pediatric'.
Inclusion criteria were applied by two reviewers and data extraction was carried out. The type of otological surgery (conservative versus extensive) and the use of anticoagulants with their clinical and radiological outcomes were tabulated.
Thirty-six studies (15 case reports and 21 case series) were included with a total of 190 patients. A total of 92.1% of patients underwent otological surgery, and 69.5% had conservative surgery and 30.5% extensive otological surgery. Anticoagulants were used in 59%. A total of 79.2% of patients were reported to have had a good clinical outcome. Within this group, 56% had conservative surgery and anticoagulants. Follow-up scans were documented in 61.6% of patients and complete recanalisation was observed in 51%. Complete recanalisation was observed in 47% of those who had been anticoagulated and 55% of those who received no anticoagulation.
Conservative otological surgery with the combination of anticoagulation was the most common treatment modality found in the group of patients with good clinical outcome. However, given the current low level of evidence, a multicentre collaborative study is needed to help establish the optimum surgical approach and the role of anticoagulation in managing paediatric otogenic CVST.
耳源性小儿脑静脉窦血栓形成(CVST)较为罕见,但具有潜在的临床后遗症。其治疗方法长期以来一直存在争议,主要涉及手术的作用以及抗凝治疗的使用。
回顾当前文献,探讨小儿耳源性CVST的内科及外科治疗方法及其临床和影像学结局。
系统综述。
从数据库建库至2014年11月,在电子数据库(MEDLINE、EMBASE、Cochrane)中进行检索,使用检索词“脑静脉窦血栓形成或脑静脉血栓形成或外侧窦血栓形成或乙状窦血栓形成”以及“耳源性或乳突炎或中耳炎”以及“儿童或小儿或儿科”。
由两名审阅者应用纳入标准并进行数据提取。将耳科手术类型(保守性手术与广泛性手术)以及抗凝剂的使用情况及其临床和影像学结局制成表格。
纳入36项研究(15篇病例报告和21篇病例系列),共190例患者。总共92.1%的患者接受了耳科手术,其中69.5%接受了保守性手术,30.5%接受了广泛性耳科手术。59%的患者使用了抗凝剂。据报告,总共79.2%的患者临床结局良好。在该组患者中,56%接受了保守性手术并使用了抗凝剂。61.6%的患者有随访扫描记录,51%观察到完全再通。接受抗凝治疗的患者中有47%观察到完全再通,未接受抗凝治疗的患者中有55%观察到完全再通。
保守性耳科手术联合抗凝治疗是临床结局良好的患者组中最常见的治疗方式。然而,鉴于目前证据水平较低,需要开展多中心合作研究,以帮助确定治疗小儿耳源性CVST的最佳手术方法以及抗凝治疗的作用。